JP2019187429A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019187429A5 JP2019187429A5 JP2019113661A JP2019113661A JP2019187429A5 JP 2019187429 A5 JP2019187429 A5 JP 2019187429A5 JP 2019113661 A JP2019113661 A JP 2019113661A JP 2019113661 A JP2019113661 A JP 2019113661A JP 2019187429 A5 JP2019187429 A5 JP 2019187429A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- ischemia
- cells
- cell
- hematopoietic stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021156680A JP2021191311A (ja) | 2011-12-02 | 2021-09-27 | 増強された幹細胞組成物 |
| JP2023017468A JP2023053019A (ja) | 2011-12-02 | 2023-02-08 | 増強された幹細胞組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161566492P | 2011-12-02 | 2011-12-02 | |
| US61/566,492 | 2011-12-02 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018244311A Division JP6775568B2 (ja) | 2011-12-02 | 2018-12-27 | 増強された幹細胞組成物 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020202687A Division JP2021036918A (ja) | 2011-12-02 | 2020-12-07 | 増強された幹細胞組成物 |
| JP2021156680A Division JP2021191311A (ja) | 2011-12-02 | 2021-09-27 | 増強された幹細胞組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019187429A JP2019187429A (ja) | 2019-10-31 |
| JP2019187429A5 true JP2019187429A5 (enExample) | 2020-01-09 |
Family
ID=48536037
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014544868A Active JP6220791B2 (ja) | 2011-12-02 | 2012-11-29 | 増強された幹細胞組成物 |
| JP2017098749A Active JP6483187B2 (ja) | 2011-12-02 | 2017-05-18 | 増強された幹細胞組成物 |
| JP2018244311A Active JP6775568B2 (ja) | 2011-12-02 | 2018-12-27 | 増強された幹細胞組成物 |
| JP2019113661A Withdrawn JP2019187429A (ja) | 2011-12-02 | 2019-06-19 | 増強された幹細胞組成物 |
| JP2020202687A Pending JP2021036918A (ja) | 2011-12-02 | 2020-12-07 | 増強された幹細胞組成物 |
| JP2021156680A Pending JP2021191311A (ja) | 2011-12-02 | 2021-09-27 | 増強された幹細胞組成物 |
| JP2023017468A Pending JP2023053019A (ja) | 2011-12-02 | 2023-02-08 | 増強された幹細胞組成物 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014544868A Active JP6220791B2 (ja) | 2011-12-02 | 2012-11-29 | 増強された幹細胞組成物 |
| JP2017098749A Active JP6483187B2 (ja) | 2011-12-02 | 2017-05-18 | 増強された幹細胞組成物 |
| JP2018244311A Active JP6775568B2 (ja) | 2011-12-02 | 2018-12-27 | 増強された幹細胞組成物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020202687A Pending JP2021036918A (ja) | 2011-12-02 | 2020-12-07 | 増強された幹細胞組成物 |
| JP2021156680A Pending JP2021191311A (ja) | 2011-12-02 | 2021-09-27 | 増強された幹細胞組成物 |
| JP2023017468A Pending JP2023053019A (ja) | 2011-12-02 | 2023-02-08 | 増強された幹細胞組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US9452186B2 (enExample) |
| EP (2) | EP2785834B1 (enExample) |
| JP (7) | JP6220791B2 (enExample) |
| CN (3) | CN112410298A (enExample) |
| AU (1) | AU2012321088B8 (enExample) |
| CA (1) | CA2857640C (enExample) |
| ES (1) | ES2836976T3 (enExample) |
| PT (1) | PT2785834T (enExample) |
| WO (1) | WO2013082243A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2785834T (pt) | 2011-12-02 | 2020-11-13 | Fate Therapeutics Inc | Composição de células estaminais melhorada |
| US10111907B2 (en) | 2011-12-02 | 2018-10-30 | Fate Therapeutics, Inc. | Methods of treating ischemia |
| JP6203820B2 (ja) | 2012-04-16 | 2017-09-27 | ケース ウエスタン リザーブ ユニバーシティ | １５−ｐｇｄｈ活性を調節する組成物および方法 |
| US9801863B2 (en) | 2012-04-16 | 2017-10-31 | Case Western Reserve University | Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis |
| WO2015065716A1 (en) | 2013-10-15 | 2015-05-07 | Case Western Reserve University | Compositions and methods of modulating short-chain dehydrogenase activity |
| US9943545B2 (en) | 2013-03-15 | 2018-04-17 | Fate Therapeutics, Inc. | Stem cell culture media and methods of enhancing cell survival |
| WO2014150602A1 (en) * | 2013-03-15 | 2014-09-25 | Fate Therapeutics, Inc. | Cell potency assay for therapeutic potential |
| ES2910654T3 (es) * | 2014-02-12 | 2022-05-13 | 7 Hills Pharma LLC | Composiciones y métodos para mejorar la migración y el injerto de células madre hematopoyéticas |
| EP3250682A4 (en) * | 2015-01-26 | 2018-08-01 | Fate Therapeutics, Inc. | Cells with increased immuno-regulatory properties and methods for their use and manufacture |
| WO2016123100A1 (en) | 2015-01-26 | 2016-08-04 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| JP2018511581A (ja) | 2015-03-08 | 2018-04-26 | ケース ウエスタン リザーブ ユニバーシティ | 線維症を処置するための短鎖デヒドロゲナーゼ活性阻害剤 |
| KR20180033537A (ko) | 2015-07-21 | 2018-04-03 | 더 칠드런스 메디칼 센터 코포레이션 | Pd-l1 발현 조혈 줄기 세포 및 용도 |
| US20170095593A1 (en) * | 2015-10-02 | 2017-04-06 | Sharon Patricia McQuillan | Adipose-derived stem cell product |
| WO2017078807A1 (en) | 2015-11-04 | 2017-05-11 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| CN108368520B (zh) | 2015-11-04 | 2023-01-17 | 菲特治疗公司 | 多能细胞的基因组工程改造 |
| JP7215994B2 (ja) | 2016-09-06 | 2023-01-31 | ザ チルドレンズ メディカル センター コーポレーション | 人工多能性幹細胞由来の免疫細胞 |
| CN110072529B (zh) * | 2016-10-14 | 2022-11-22 | 济州大学校产学协力团 | 包含环索奈德的用于抑制癌症干细胞的生长的组合物 |
| EP3548035A4 (en) | 2016-11-30 | 2020-07-22 | Case Western Reserve University | COMBINATIONS OF 15-PGDH INHIBITORS WITH CORCOSTEROIDS AND / OR TNF INHIBITORS AND THEIR USES |
| AU2018215678A1 (en) | 2017-02-06 | 2019-08-22 | Board Of Regents Of The University Of Texas System | Compositions and methods of modulating short-chain dehydrogenase activity |
| US11879137B2 (en) | 2017-09-22 | 2024-01-23 | The Children's Medical Center Corporation | Treatment of type 1 diabetes and autoimmune diseases or disorders |
| US11285177B2 (en) | 2018-01-03 | 2022-03-29 | Globus Medical, Inc. | Allografts containing viable cells and methods thereof |
| WO2020021540A1 (en) | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of pancreatic diseases |
| WO2020021538A1 (en) | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of brain diseases |
| ES2992862T3 (en) | 2018-07-22 | 2024-12-18 | Minovia Therapeutics Ltd | Mitochondrial augmentation therapy of renal diseases |
| JP7522095B2 (ja) | 2018-07-22 | 2024-07-24 | ミノヴィア セラピューティクス リミテッド | 原発性ミトコンドリア病のためのミトコンドリア増強療法 |
| US12239672B2 (en) | 2018-07-22 | 2025-03-04 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of ocular diseases |
| IL321451A (en) | 2018-11-21 | 2025-08-01 | Univ Case Western Reserve | Compositions and methods of modulating short-chain dehydrogenase activity |
| MX2022010258A (es) | 2020-02-21 | 2023-01-24 | Univ Case Western Reserve | Composiciones y métodos para tratar la lesión renal. |
| EP4125948A4 (en) | 2020-03-31 | 2024-05-29 | Minovia Therapeutics Ltd. | Mitochondria-enriched genetically engineered cells and uses thereof |
| CN113069460B (zh) * | 2021-03-24 | 2022-02-08 | 兰州大学 | 哈西奈德及其衍生物用于制备治疗和/或预防脑血管疾病药物中的应用 |
| CN114848675A (zh) * | 2022-06-24 | 2022-08-05 | 南开大学 | Pge2赋能的间充质干细胞制剂在制备治疗肺损伤药物中的应用 |
| GB202211232D0 (en) | 2022-08-02 | 2022-09-14 | Heptares Therapeutics Ltd | Prostaglandin EP4 receptor agonist compounds |
| WO2025155768A1 (en) * | 2024-01-17 | 2025-07-24 | Rhode Island Hospital | A motile injectable cell that accelerates musculoskeletal connective tissue repair |
Family Cites Families (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4839032B1 (enExample) | 1964-09-11 | 1973-11-21 | ||
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5077049A (en) | 1989-07-24 | 1991-12-31 | Vipont Pharmaceutical, Inc. | Biodegradable system for regenerating the periodontium |
| DK0423980T3 (da) | 1989-10-16 | 2000-10-09 | Amgen Inc | Stamcellefaktor |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5635387A (en) | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
| AU2882992A (en) | 1991-11-06 | 1993-06-07 | Arthur A. Axelrad | Cell culture medium |
| JP2795014B2 (ja) | 1991-11-29 | 1998-09-10 | 東洋インキ製造株式会社 | 保存温度管理用インジケーター |
| US5460964A (en) | 1992-04-03 | 1995-10-24 | Regents Of The University Of Minnesota | Method for culturing hematopoietic cells |
| US5442033A (en) | 1993-07-20 | 1995-08-15 | Ethicon, Inc. | Liquid copolymers of epsilon-caprolactone and lactide |
| WO1995006112A1 (en) | 1993-08-23 | 1995-03-02 | Baxter International Inc. | In vitro growth of neutrophil and megakaryocyte precursors in serum-free media |
| US5409813A (en) | 1993-09-30 | 1995-04-25 | Systemix, Inc. | Method for mammalian cell separation from a mixture of cell populations |
| US5648331A (en) | 1994-08-26 | 1997-07-15 | G.D. Searle & Co. | Method of inhibiting tissue ischemia and reperfusion injury |
| US5677136A (en) | 1994-11-14 | 1997-10-14 | Systemix, Inc. | Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
| US5753516A (en) | 1995-02-03 | 1998-05-19 | Heagy; Wyrta E. | Screening method for ligands of the EBI-1 receptor |
| WO1996040866A1 (en) | 1995-06-07 | 1996-12-19 | Novartis Ag | Serum-free media for primitive hematopoietic cells and methods of use thereof |
| US5709472A (en) | 1995-10-23 | 1998-01-20 | Lifelines Technology, Inc. | Time-temperature indicator device and method of manufacture |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| US5945337A (en) | 1996-10-18 | 1999-08-31 | Quality Biological, Inc. | Method for culturing CD34+ cells in a serum-free medium |
| US6372796B1 (en) | 1996-11-13 | 2002-04-16 | Cold Spring Harbor Laboratory | Therapeutic uses for nitric oxide inhibitors |
| US6191109B1 (en) | 1997-10-31 | 2001-02-20 | Children's Hospital, Inc. | Methods of treating intestinal ischemia using heparin-binding epidermal growth factor |
| DE69817995T2 (de) | 1998-01-05 | 2004-07-22 | Mitra Industries Ltd. | Flexibler, zusammenfaltbarer Blutbeutel |
| IL125532A0 (en) * | 1998-07-27 | 1999-03-12 | Yeda Res & Dev | Hematopoietic cell composition for use in transplantation |
| AU2183900A (en) | 1998-12-24 | 2000-07-31 | Alcon Laboratories, Inc. | Ep4 receptor agonists for treatment of dry eye |
| US6946293B1 (en) | 1999-02-10 | 2005-09-20 | Es Cell International Pte Ltd. | Progenitor cells, methods and uses related thereto |
| GB9904281D0 (en) | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
| EP1219600A4 (en) | 1999-08-13 | 2004-11-03 | Taisho Pharmaceutical Co Ltd | PROSTAGLANDIN DERIVATIVES |
| TWI247606B (en) | 1999-11-24 | 2006-01-21 | Ono Pharmaceutical Co | Treating agent for osteopenic diseases |
| BR0015781A (pt) | 1999-11-24 | 2002-12-31 | Ono Pharmaceutical Co | Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea |
| PT1132086E (pt) | 2000-01-31 | 2006-09-29 | Pfizer Prod Inc | Utilizacao de agonistas selectivos para o receptor da prostaglandina (pge2) 4 (ep4) para o tratamento de falha renal aguda e cronica |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| US7179643B2 (en) | 2001-06-14 | 2007-02-20 | Reliance Life Sciences Pvt. Ltd. | Device and a process for expansion of haemopoeitic stem cells for therapeutic use |
| IL162648A0 (en) | 2001-12-21 | 2005-11-20 | Mount Sinai Hospital Corp | Cellular compositions and methods of making and using them |
| EP1348758A1 (en) | 2002-03-28 | 2003-10-01 | Boehringer Ingelheim Pharma GmbH & Co.KG | Host cells having improved cell survival properties and methods to generate such cells |
| RU2205627C1 (ru) | 2002-05-30 | 2003-06-10 | Открытое акционерное общество "Косметическое объединение "Свобода" | Крем для лица, выводящий токсины |
| EP1563846B1 (en) | 2002-10-10 | 2012-08-29 | Ono Pharmaceutical Co., Ltd. | Endogenous repair factor production promoters |
| JP2006519250A (ja) | 2003-03-04 | 2006-08-24 | ファイザー・プロダクツ・インク | 医療処置におけるｅｐ２選択的受容体アゴニストの使用 |
| AU2004217699B2 (en) | 2003-03-07 | 2008-07-03 | Gamida-Cell Ltd. | Expansion of renewable stem cell populations using modulators of PI 3-kinase |
| WO2004081196A2 (en) | 2003-03-11 | 2004-09-23 | Qlt Usa Inc. | Formulations for cell- schedule dependent anticancer agents |
| CA2519975C (en) | 2003-04-08 | 2013-07-02 | Yeda Research And Development Co. Ltd | Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same |
| US6747037B1 (en) | 2003-06-06 | 2004-06-08 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US8309608B2 (en) | 2003-11-06 | 2012-11-13 | Sanofi-Aventis Deutschland Gmbh | Use of eNOS transcription enhancers in the cell therapy of ischemic heart diseases |
| IL158868A0 (en) | 2003-11-13 | 2004-05-12 | Yeda Res & Dev | Methods of generating and using stem cells enriched with immature primitive progenitor |
| US8328876B2 (en) | 2003-12-31 | 2012-12-11 | Warsaw Orthopedic, Inc. | Bone matrix compositions and methods |
| JP2005220089A (ja) | 2004-02-06 | 2005-08-18 | Menicon Co Ltd | 組織等価物用パッケージ |
| US20050176140A1 (en) | 2004-02-10 | 2005-08-11 | Benedict Daniel J. | Method and apparatus for cell culture using a two liquid phase bioreactor |
| US7004621B2 (en) | 2004-06-17 | 2006-02-28 | Cryovac, Inc. | Method of monitoring temperature exposure |
| JP4086816B2 (ja) | 2004-07-01 | 2008-05-14 | 株式会社Ｎｅｃ情報システムズ | Ｂｇａ部品搭載基板の層数見積もり装置及び方法並びに層数見積もりプログラム |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| EP2360242A1 (en) * | 2004-09-24 | 2011-08-24 | Angioblast Systems, Inc. | Method of enhancing proliferation and/or survival of mesenchymal procursor cells (MPC) |
| ES2538305T3 (es) * | 2004-10-25 | 2015-06-18 | Cellerant Therapeutics, Inc. | Métodos para expandir poblaciones de células mieloides y usos de las mismas |
| JP2008518013A (ja) | 2004-10-26 | 2008-05-29 | アラーガン、インコーポレイテッド | プロスタグランジンｅｐ４アゴニストによる処置方法およびデリバリー方法 |
| WO2006078886A2 (en) | 2005-01-18 | 2006-07-27 | Irm Llc | Compounds and compositions as wnt signaling pathway modulators |
| EP1859028B1 (en) | 2005-02-10 | 2015-12-02 | Regents Of The University Of Minnesota | Vascular endothelial cells |
| JP4839032B2 (ja) * | 2005-07-13 | 2011-12-14 | 国立大学法人 岡山大学 | ケモカイン受容体作用増強剤 |
| US20090220465A1 (en) | 2005-11-07 | 2009-09-03 | The General Hospital Corporation | Methods and compositions for modulation of stem cell aging |
| AU2006326853B2 (en) | 2005-12-22 | 2012-02-16 | Es Cell International Pte Ltd | Direct differentiation of cardiomyocytes from human embryonic stem cells |
| DE102005062741A1 (de) | 2005-12-22 | 2007-06-28 | Bayer Schering Pharma Ag | Fluorene und Carbazole als Liganden des EP2 Rezeptors |
| CN101415814A (zh) | 2006-02-08 | 2009-04-22 | 贝克顿·迪金森公司 | 改进的样本收集和储存装置以及与其相关的方法 |
| MX373998B (es) | 2006-03-24 | 2020-07-22 | Childrens Medical Center | Uso de un modulador de células madre hematopoyeticas (hsc) para promover el crecimiento de hsc. |
| WO2008088379A2 (en) | 2006-07-14 | 2008-07-24 | Xcellerex, Inc. | Environmental containment systems |
| US20100233135A1 (en) | 2006-08-16 | 2010-09-16 | The General Hospital Corporation | Compositions and methods for hematopoietic stem cell expansion or for modulating angiogenesis |
| KR20080042761A (ko) | 2006-11-10 | 2008-05-15 | 문찬일 | 렙틴을 이용한 줄기세포 증식방법 |
| EP2094839B1 (en) * | 2006-12-08 | 2020-02-05 | University of Rochester | Expansion of hematopoietic stem cells |
| US8871752B2 (en) | 2008-02-19 | 2014-10-28 | Sucampo Ag | Method for modulating stem cell growth |
| WO2009134532A2 (en) | 2008-03-07 | 2009-11-05 | The Trustees Of Columbia University In The City Of New York | Homing in mesenchymal stem cells |
| EP3031907B1 (en) | 2008-11-06 | 2021-01-06 | Indiana University Research and Technology Corporation | Materials and methods to enhance hematopoietic stem cells engraftment procedures |
| EP2367432B1 (en) | 2008-12-03 | 2017-08-30 | Amorcyte, Inc. | Infarct area perfusion-improving composition |
| EP3533445A1 (en) | 2009-03-19 | 2019-09-04 | Fate Therapeutics, Inc. | Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same |
| EP2275442A1 (en) * | 2009-07-06 | 2011-01-19 | Ludwig-Maximilians-Universität München | Detection and vizualization of the cell cycle in living cells |
| EP2603227B1 (en) * | 2010-08-12 | 2017-10-04 | Fate Therapeutics, Inc. | Improved hematopoietic stem and progenitor cell therapy |
| PT2785834T (pt) | 2011-12-02 | 2020-11-13 | Fate Therapeutics Inc | Composição de células estaminais melhorada |
| US10111907B2 (en) | 2011-12-02 | 2018-10-30 | Fate Therapeutics, Inc. | Methods of treating ischemia |
-
2012
- 2012-11-29 PT PT128542388T patent/PT2785834T/pt unknown
- 2012-11-29 CN CN202011283992.5A patent/CN112410298A/zh active Pending
- 2012-11-29 WO PCT/US2012/066987 patent/WO2013082243A1/en not_active Ceased
- 2012-11-29 CA CA2857640A patent/CA2857640C/en active Active
- 2012-11-29 AU AU2012321088A patent/AU2012321088B8/en active Active
- 2012-11-29 EP EP12854238.8A patent/EP2785834B1/en active Active
- 2012-11-29 JP JP2014544868A patent/JP6220791B2/ja active Active
- 2012-11-29 CN CN201280067558.0A patent/CN104066837B/zh active Active
- 2012-11-29 US US14/362,386 patent/US9452186B2/en active Active
- 2012-11-29 EP EP20197373.2A patent/EP3785767A1/en not_active Withdrawn
- 2012-11-29 CN CN202011283996.3A patent/CN112375734A/zh active Pending
- 2012-11-29 ES ES12854238T patent/ES2836976T3/es active Active
-
2016
- 2016-09-02 US US15/256,133 patent/US10172888B2/en active Active
-
2017
- 2017-05-18 JP JP2017098749A patent/JP6483187B2/ja active Active
-
2018
- 2018-12-12 US US16/218,314 patent/US11052118B2/en active Active
- 2018-12-27 JP JP2018244311A patent/JP6775568B2/ja active Active
-
2019
- 2019-06-19 JP JP2019113661A patent/JP2019187429A/ja not_active Withdrawn
-
2020
- 2020-12-07 JP JP2020202687A patent/JP2021036918A/ja active Pending
-
2021
- 2021-06-04 US US17/339,440 patent/US20220118021A1/en not_active Abandoned
- 2021-09-27 JP JP2021156680A patent/JP2021191311A/ja active Pending
-
2023
- 2023-02-08 JP JP2023017468A patent/JP2023053019A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021036918A5 (enExample) | ||
| Pyšná et al. | Endothelial progenitor cells biology in diabetes mellitus and peripheral arterial disease and their therapeutic potential | |
| Kanji et al. | Advances of stem cell therapeutics in cutaneous wound healing and regeneration | |
| Ho et al. | Current advancements and strategies in tissue engineering for wound healing: a comprehensive review | |
| Nguyen et al. | Stromal vascular fraction: A regenerative reality? Part 1: Current concepts and review of the literature | |
| Patel et al. | The role of endothelial cells and their progenitors in intimal hyperplasia | |
| Przybyt et al. | Mesenchymal stem cells: promising for myocardial regeneration? | |
| JP2015504313A5 (enExample) | ||
| Castro et al. | Cellular and molecular heterogeneity associated with vessel formation processes | |
| JP2015505829A5 (enExample) | ||
| RU2010116271A (ru) | Ангиогенные клетки из плацентарного перфузата человека | |
| RU2011111938A (ru) | Выращенные в прикрепленной к субстрату культуре клетки из ткани плаценты и их использование при лечении | |
| Jiang et al. | Progress in stem cell therapy for the diabetic foot | |
| Obi et al. | Effects of shear stress on endothelial progenitor cells | |
| Athanassopoulos et al. | Microvessel networks in pre-formed in artificial clinical grade dermal substitutes in vitro using cells from haematopoietic tissues | |
| Siepe et al. | Stem cell research and cell transplantation for myocardial regeneration | |
| Wang et al. | Regenerative therapy for cardiomyopathies | |
| Loisel et al. | Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy? | |
| Suzuki et al. | Omentopexy enhances graft function in myocardial cell sheet transplantation | |
| Maeda et al. | Impact of mesenchymal stromal cell delivery through cardiopulmonary bypass on postnatal neurogenesis | |
| Turksen | Adult stem cells and cardiac regeneration | |
| Xu et al. | Generation of induced cardiac progenitor cells via somatic reprogramming | |
| He et al. | Recent advances in mesenchymal stem cell therapy for myocardial infarction | |
| Biscetti et al. | The angiogenic properties of human adipose-derived stem cells (HASCs) are modulated by the High mobility group box protein 1 (HMGB1) | |
| Tonkin et al. | Healing the ischaemic heart: a critical review of stem cell therapies |